ММВБ 2 989 -0,1%  Nasdaq 11 108 1,0%  Биткойн 11 885 0,9%  USD/RUB 73,2984 -0,1% 
РТС 1 282 -1,0%  S&P500 3 349 0,6%  Нефть 45,1 0,0%  EUR/RUB 86,7800 -0,4% 
Dow 27 387 0,7%  FTSE100 6 027 -1,3%  Золото 2 070 0,3%  EUR/USD 1,1837 -0,4% 

Курс акций EVOTEC [ISIN: DE0005664809]


EVOTEC SE - Профиль

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmes on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.


Название Доля (%)
Novo Nordisk Fonden9,80
Roland Oetker8,96
T. Rowe Price Associates, Inc. (Investment Management)7,44
Allianz Global Investors GmbH5,03
DWS Investment GmbH5,02
DWS Deutschland2,96
Goldman Sachs Asset Management LP2,82
T Rowe Price International Stock Fund2,05
DWS Aktien Strategie Deutschland1,55
Government Pension Fund - Global (The)1,55
Vanguard Total International Stock Index Fund1,51
DWS Investa1,42
T Rowe Price Overseas Stock Fund1,13


Manfred Eigen Campus, 22419 Hamburg
Телефон: +49 (40) 56081-0
Факс: +49 (40) 56081-222
Вэб: http://evotec.com


Wolfgang Plischke
Chairman-Supervisory Board
Werner Lanthaler
Chief Executive Officer
Enno Spillner
Chief Financial Officer
Craig L. Johnstone
Chief Operating Officer & Member-Management Board
Cord E. Dohrmann
Chief Scientific Officer
Mario Eugenio Cosimino Polywka
Member-Supervisory Board
Elaine Sullivan
Member-Supervisory Board
Roland Sackers
Member-Supervisory Board
Michael Shalmi
Member-Supervisory Board
Gabriele Hansen
VP-Marketing, Communications & Investor Relations
Iris Löw-Friedrich
Vice Chairman-Supervisory Board

Добавить или редактировать инструмент